Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?

CINtec PLUS HPV DNA cancer biomarkers cervical cancer screening high-risk HPV p16/Ki67 dual-stain triage young women

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
29 Oct 2021
Historique:
received: 17 10 2021
accepted: 26 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Recently, cervical cancer rates elevation has been noted in women aged 20-39 years in regions with a very high human development index (HDI). The onset of cancer elevation rates is observed in the age range of 25-29 years, which should necessitate effective precancer screening in younger age groups, including those <25 years. From 30.066 liquid-based screening tests results (

Identifiants

pubmed: 34829358
pii: diagnostics11112012
doi: 10.3390/diagnostics11112012
pmc: PMC8624363
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Mod Pathol. 2017 Jul;30(7):1021-1031
pubmed: 28304400
Gynecol Oncol. 2017 Jan;144(1):51-56
pubmed: 28094038
BMC Med. 2013 Oct 22;11:227
pubmed: 24148310
Cancer Cytopathol. 2015 Jun;123(6):373-81
pubmed: 25891096
Arch Pathol Lab Med. 2012 Oct;136(10):1266-97
pubmed: 22742517
CA Cancer J Clin. 2020 Sep;70(5):321-346
pubmed: 32729638
Gynecol Oncol. 2011 Jun 1;121(3):505-9
pubmed: 21420158
J Low Genit Tract Dis. 2018 Oct;22(4):348-351
pubmed: 30169418
Lancet Oncol. 2017 Dec;18(12):1579-1589
pubmed: 29111259
Ginekol Pol. 2021;92(2):165-173
pubmed: 33751524
JAMA Intern Med. 2019 Jul 1;179(7):881-888
pubmed: 31081870
Lancet Oncol. 2006 Jul;7(7):547-55
pubmed: 16814206
J Natl Cancer Inst. 2021 Mar 1;113(3):292-300
pubmed: 32745170
J Low Genit Tract Dis. 2020 Apr;24(2):102-131
pubmed: 32243307
BMJ. 2016 Jul 28;354:i3633
pubmed: 27469988
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
J Glob Oncol. 2016 Oct 12;3(5):635-657
pubmed: 29094101
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
JAMA Oncol. 2019 Feb 1;5(2):181-186
pubmed: 30325982
Clin Cancer Res. 2012 Aug 1;18(15):4154-62
pubmed: 22675168
JAMA Oncol. 2017 Jun 1;3(6):833-837
pubmed: 27685805
Cancer Cytopathol. 2011 Jun 25;119(3):158-66
pubmed: 21442767

Auteurs

Martyna Trzeszcz (M)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.
Division of Pathology and Clinical Cytology, University Hospital in Wroclaw, Borowska 213, 50-556 Wroclaw, Poland.

Maciej Mazurec (M)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Robert Jach (R)

Division of Gynecologic Endocrinology, Jagiellonian University Medical College, Kopernika 23, 31-501 Krakow, Poland.
Superior Medical Center, Czyzynska 21/50, 31-571 Krakow, Poland.

Karolina Mazurec (K)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Zofia Jach (Z)

Superior Medical Center, Czyzynska 21/50, 31-571 Krakow, Poland.

Izabela Kotkowska-Szeps (I)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Magdalena Kania (M)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Mariola Wantuchowicz (M)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Anna Prokopyk (A)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Piotr Barcikowski (P)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Marcin Przybylski (M)

Department of Obstetrics and Gynecology, District Public Hospital, Juraszow 7-19, 60-479 Poznan, Poland.

Joanna Wach (J)

Corfamed Woman's Health Center, Kluczborska 37, 50-322 Wroclaw, Poland.

Agnieszka Halon (A)

Department of Clinical and Experimental Pathology, Division of Clinical Pathology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.

Classifications MeSH